Platinum-sensitivity status was not associated with PFS ( HR , 1.11 ; p = 0.49 ) or OS ( HR , 1.25 ; p = 0.14 ) , except in a model that excluded 36 patients who received more than one prior chemotherapy regimen ( HR , 1.34 ; p = 0.049 ) .